Pay in 4 interest-free payments of $33.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Thalidomide 4-ether-alkylC2-acid
Preclinical studies indicate that LX7101 significantly reduced intraocular pressure in both mouse and monkey models
InChi: InChI=1S/C27H35N3O3/c1-2-14-29(13-1)17-5-19-31-23-9-7-22(8-10-23)27-28-25-12-11-24(21-26(25)33-27)32-20-6-18-30-15-3-4-16-30/h7-12
SW044248 killed approximately 15% of a panel of 74 NSCLC cell lines and was nontoxic to immortalized human bronchial cell lines
and 2a (JFH-1)-derived replicons and GT 1b chimeric replicons containing the NS5B region from the J6 GT 2a isolate and from GT 2b and GT 3a patient isolates is evaluated
SR-3306 HA-665752 Thalidomide 4-ether-alkylC2-acidSR 3306 is an aminopyrimidine JNK inhibitor. SR 3306 reduces the loss of dopaminergic cell bodies in the SNpc and their terminals in the striatum produced by unilateral injection of 6 hydroxydopamine (6 OHDA) into the nigrostriatal pathway. Product information CAS Number: 1128096 91 2 Molecular Weight: 490. 56 Formula: C28H26N8O Chemical Name: N {4 [3 (6 methylpyridin 3 yl) 1H 1,2,4 triazol 1 yl]phenyl} 4 [3 (morpholin 4 yl)phenyl]pyrimidin 2 amine
US$ 62.99
US$ 137.50
US$ 149.50
US$ 187.50
US$ 125.00
US$ 147.50
US$ 2500.00
US$ 150.00
US$ 150.00
US$ 619.60